Abstracts Topics
|
✔ | Addressing the Global CV Risk Factors in Pre-Disease and in Disease | ✔ | The Heart, the Brain and the Kidney in Pre-Disease and the Metabolic Syndrome |
✔ | Arterial Properties, Central Blood Pressure and Augmentation Index in Pre-Disease and Disease in Patients with Cardiometabolic Syndrome | ✔ | PreHypertension and Metabolic Syndrome in Different Populations – Epidemiologic Aspects |
✔ | Arterial Properties, Evaluation and Treatment in Metabolic Syndrome | ✔ | Prediabetes – Mechanisms, Diagnosis and Management |
✔ | Benefits of Achieving Optimal Risk Factors Level – When, How and with What? | ✔ | PreHypertension, Hypertension and Renal Denervation |
✔ | Cardiometabolic Syndrome in Children | ✔ | Metabolic Syndrome and Vitamin D |
✔ | Children and Adolescents: PreHypertension and Metabolic Syndrome, Progression of Risk and Diagnosis of Disease | ✔ | PreHypertension, Prediabetes and Dyslipidemia – Estimation of Risk and Therapeutic Approach |
✔ | Effect of Pre-Disease Risk Factors in Patients with the Metabolic Syndrome on Morbidity and Mortality | ✔ | Which Elderly Patients with Pre-Disease should be Considered for Medical Treatment |
✔ | Gestational Prehypertension and Gestational Hypertension | ✔ | Total Cardiovascular Risk Evaluation and Management |
✔ | Cardiac Markers of Pre-Clinical Disease in Metabolic Syndrome Patients | ✔ | Pre-Levels of CV Risk Factors – Boosting Risk of Events and Deciding Who Should be Treated |